Science Pool

Discovery of GluN2A-Selective NMDA Receptor Positive Allosteric Modulators

Posted by Evotec on Mar 4, 2021 9:47:46 PM

Tags: Neuroscience, Medicinal Chemistry, Articles & Whitepapers

Lead Optimization of Novel Interleukin-2 Inducible T-Cell Kinase (ITK) Inhibitors

Posted by Evotec on Mar 4, 2021 9:46:18 PM

Tags: Medicinal Chemistry, Respiratory, Articles & Whitepapers, Immunology & Inflammation

SAR & Optimization of Proline-based CB2 Receptor Agonists

Posted by Evotec on Mar 2, 2021 12:58:26 PM

Tags: Medicinal Chemistry, Articles & Whitepapers

Synthesis and SAR of Novel 5-Lipoxygenase Activating Protein Inhibitors

Posted by Evotec on Mar 2, 2021 12:43:07 PM

Tags: Medicinal Chemistry, Articles & Whitepapers

Cheminformatics Approach to Designing a 3D Fragment Library

Posted by Evotec on Feb 24, 2021 1:20:05 PM

Tags: Medicinal Chemistry, Posters

The Use of QED to Estimate Antibacterial Drug-Likeness

Posted by Evotec on Feb 24, 2021 1:14:54 PM

Tags: Medicinal Chemistry, Posters, Anti-Infectives

Targeting Immunosuppressive Cell Trafficking

Posted by Evotec on Feb 24, 2021 12:40:59 PM

Tags: Medicinal Chemistry, Oncology, Posters

Tuning Covalent Reactivity: A Chemist’s Toolbox

Posted by Evotec on Feb 20, 2021 2:17:37 PM

Tags: Medicinal Chemistry, Posters

Integrated Drug Discovery Fact Sheet

Posted by Evotec on Feb 10, 2021 10:51:44 AM

Download this fact sheet to learn more about building integrated drug discovery and development partnerships at Evotec including:

  • Our proven track record
  • Innovative scientific and commercial solutions across all modalities progressing
  • Combination of state-of-the-art capabilities and fully integrated interdisciplinary approach
DOWNLOAD

Tags: Medicinal Chemistry, Fact Sheets